BlackRock Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$7.25M Buy
2014
Q4
$5.39M Sell
2014
Q3
$4.01M Sell
2014
Q2
$6.13M Buy
2014
Q1
$4.72M Buy
2013
Q4
$3.42M Buy
2013
Q3
$3.06M Buy
2013
Q2
$1.89M Buy